Sanofi hints at higher Genzyme bid

The ongoing negotiation-by-leak between Sanofi-Aventis and Genzyme picked up speed over the long weekend. A source on the bidding team indicated to Dow Jones that Sanofi is willing to modestly hike its $69 offer--if it gets Genzyme to the bargaining table. GlaxoSmithKline R&D chief Moncef Slaoui, meanwhile, told a French newspaper that the big U.K. pharma company won't be suiting up to play the role of White Knight. Report